Coronavirus | Mumbai-based Haffkine gets Centre’s nod to produce Covaxin
The Hindu
Haffkine Biopharma Corporation, Mumbai, has received permission from the Union government to manufacture Covaxin, an anti-coronavirus vaccine of Bharat Biotech, on technology transfer basis. Chief Min
Haffkine Biopharma Corporation, Mumbai, has received permission from the Union government to manufacture Covaxin, an anti-coronavirus vaccine of Bharat Biotech, on technology transfer basis. Chief Minister Uddhav Thackeray thanked Prime Minister Narendra Modi for this late on Thursday evening. The State government had sent the proposal to the Centre in the last week of February saying the infrastructure of Haffkine, which is known for vaccine production, could be used for corona vaccine production in the country. Mr. Thackeray had even raised the issue in his video-conference with Mr. Modi, last month.More Related News

Scaling Artificial Intelligence(AI) at the speed at which consultants project is not possible by the laws of physics and may not be environmentally sustainable, said Tanvir Khan, who is the Executive Vice President and Chief Operating Officer of NTT DATA North America, part of the Japanese technology services and data centre company NTT Data, in an interview with The Hindu.












